Journal article icon

Journal article

Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units

Abstract:
BACKGROUND: Late-phase platform protocols (including basket, umbrella, multi-arm multi-stage (MAMS), and master protocols) are generally agreed to be more efficient than traditional two-arm clinical trial designs but are not extensively used. We have gathered the experience of running a number of successful platform protocols together to present some operational recommendations. METHODS: Representatives of six UK clinical trials units with experience in running late-phase platform protocols attended a 1-day meeting structured to discuss various practical aspects of running these trials. We report and give guidance on operational aspects which are either harder to implement compared to a traditional late-phase trial or are specific to platform protocols. RESULTS: We present a list of practical recommendations for trialists intending to design and conduct late-phase platform protocols. Our recommendations cover the entire life cycle of a platform trial: from protocol development, obtaining funding, and trial set-up, to a wide range of operational and regulatory aspects such as staffing, oversight, data handling, and data management, to the reporting of results, with a particular focus on communication with trial participants and stakeholders as well as public and patient involvement. DISCUSSION: Platform protocols enable many questions to be answered efficiently to the benefit of patients. Our practical lessons from running platform trials will support trial teams in learning how to run these trials more effectively and efficiently
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s13063-022-06680-4

Authors

More by this author
Role:
Author
ORCID:
0000-0002-6695-5390
More by this author
Role:
Author
ORCID:
0000-0002-0973-660X
More by this author
Role:
Author
ORCID:
0000-0002-3286-0676
More by this author
Role:
Author
ORCID:
0000-0001-5040-6381
More by this author
Role:
Author
ORCID:
0000-0003-0599-0245


More from this funder
Funder identifier:
10.13039/501100000289
Grant:
C22436/A25354
More from this funder
Funder identifier:
10.13039/501100000265
Grant:
MC_UU_00004/08
More from this funder
Funder identifier:
10.13039/100012068


Publisher:
BioMed Central
Journal:
Trials More from this journal
Volume:
23
Issue:
1
Pages:
757-757
Article number:
757
Publication date:
2022-09-06
DOI:
EISSN:
1745-6215
ISSN:
1745-6215


Language:
English
Keywords:
Pubs id:
1278095
Local pid:
pubs:1278095
Source identifiers:
W4294845172
Deposit date:
2026-04-28
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP